GlycoMimetics, Inc.
GLYC
$0.2446
-$0.0301-10.96%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 26.48% | 2.69% | 5.97% | -18.26% | 1.35% |
| Total Depreciation and Amortization | -100.00% | -34.68% | -15.07% | -37.34% | -45.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -31.06% | 15.37% | 1.65% | 22.55% | 2.29% |
| Change in Net Operating Assets | 1,208.10% | 179.10% | 80.49% | -494.93% | 146.98% |
| Cash from Operations | 53.70% | 10.11% | 15.37% | -38.00% | 12.30% |
| Capital Expenditure | -- | 100.00% | 66.22% | -825.00% | 89.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | 66.22% | -825.00% | 89.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -89.80% | 390.00% | -98.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -89.80% | 390.00% | -98.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 54.07% | 10.13% | 15.37% | -38.04% | 11.76% |